A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Pfizer
Xim Limited
Merck Sharp & Dohme LLC
Bayer
Bayer
Menarini International Operations Luxembourg SA
AVEO Pharmaceuticals, Inc.
Apeiron Biologics
Eli Lilly and Company